Synthorx proposes $100M IPO ahead of synthetic IL-2 clinical testing

Synthetic biology company Synthorx Inc. (La Jolla, Calif.) proposed to raise $100 million in a NASDAQ IPO, according to an SEC filing from Nov. 13.

Synthorx

Read the full 253 word article

User Sign In